Forecast
22
Laboratories( NABL)
RELATED REPORTS
RELATED REPORTS
SR. NO. REPORT TITLE PUBLISHED DATE
1
IN VITRO DIAGNOSTICS( IVD) MARKET By Product( instruments, Reagents, Software, Service) Technology( Immunoassay, Clinical Chemistry, Molecular Diagnostics, Hematology) by Application( Diabetes, Cancer, Cardiology, Autoimmune Diseases)- Forecast to 2020
July 2015
2
MOLECULAR DIAGNOSTICS MARKET By Application( Infectious Disease( HIV, HPV, TB), Oncology, Genetics, Microbiology), Technology( PCR, Microarray, DNA Sequencing), End User( Hospital, Laboratories), Product( Instruments, Reagent, Software)- Forecast to 2020
November 2015
U. S. In Vitro Diagnostics( IVD) Market – Forecast to 2020
1.3.1 MARKETS COVERED This research report categorizes the in vitro diagnostics( IVD) market into the following segments:
FIGURE 1 U. S. IN VITRO DIAGNOSTICS MARKET
BY PRODUCTS & SERVICES
• Instruments
• Fully Automated
• Semi Automated
• Others
• Reagents
• Data Management Software
• Services
Note 1: Other IVD technologies include flow cytometry, In-situ hybridization and Fluorescence in situ hybridization( FISH), and selfblood glucose monitoring.
2: Other applications include blood analysis tests, urine analysis tests, pregnancy tests, and general clinical applications.
3: Other end users( include physician office laboratories, blood banks, home health agencies, nursing homes, ambulatory surgical centers, and patient self-testing)
U. S. In Vitro Diagnostics End User Market, by Region
• Clinical Laboratories / Independent Laboratories Market, by Region
• South
• West
• Midwest
• Northeast
• Hospital Laboratories Market, by Region
• South
• West
• Midwest
• Northeast
U. S. IN VITRO DIAGNOSTICS MARKET
BY TECHNOLOGY
• Clinical Chemistry
• Immunoassays / Immunoch emistry
• Hematology
• Coagulation and Hemostasis
• Microbiology
• Molecular Diagnostics
• Other IVD Technologies
BY APPLICATION
• Diabetes
• Bone & Mineral Disorders
• Infectious Diseases
• Oncology / Cancer
• Endocrine Disorders
• Cardiovascular Disorders
• Pulmonary Disorders
• Autoimmune Diseases
• Other Applications
BY END USER
• Clinical / Independent Laboratories
• Large-sized Laboratories / Refere nce Laboratories
• Medium-sized Laboratories
• Small-sized Laboratories
• Hospital Laboratories
• Other End Users
U. S. In Vitro Diagnostics( IVD) Market – Forecast to 2020
1.3.2 YEARS CONSIDERED FOR THE STUDY
2013
HISTORICAL YEAR
Note: For market estimates, the calendar year has been considered; whereas, for company profiles, the fiscal year has been considered.
1.4 CURRENCY The currency used in the report is USD($), with market size indicated in USD million.
• For companies reporting their revenues in USD, the revenues were picked from their annual reports
• For companies that reported their revenues in other currencies, the average annual currency conversion rate was used for that particular year to convert the value to USD
1.5 LIMITATIONS
• The company developments not reported in the public domain are not included in the report
• The report does not provide the volume market for devices / products used during the IVD
procedure
1.6 STAKEHOLDERS
2014
BASE YEAR
• IVD Product Manufacturers
• Group Purchase Organizations( GPOs)
• OEM Manufacturers
• Pathologists and Pathology Laboratories
• Distributors of IVD Products
• Hospitals and Clinics
• Healthcare Institutions
• Research Institutes
2015-e
ESTIMATED YEAR
2015-2020
U. S. In Vitro Diagnostics( IVD) Market – Forecast to 2020
2 RESEARCH METHODOLOGY
2.1 RESEARCH DATA
FORECAST PERIOD
This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the regulatory landscape; competitive scenario; historic data; current trends in the market; technological innovation and upcoming technologies; and market drivers, restraints, opportunities, and challenges.
The following illustrative figure shows the market research methodology applied in making this report on the U. S. in vitro diagnostics( IVD) market.
FIGURE 2 RESEARCH DESIGN
HISTORICAL DATA FOR THE U. S. IN VITRO
MARKET
DIAGNOSTICS
INFLUENCING FACTORS( Market Trends and Dynamics)
FORECAST PERIOD( 2015 – 2020)
COST OF PRODUCTS AND DIAGNOSTIC TESTS COMPANY REVENUES & R & D EXPENSES
MARKET DRIVERS:
• Rapid growth in the geriatric population and increasing incidence of chronic diseases in the U. S.
• Increasing adoption of pointof-care testing
• Growing awareness on personalized medicine
• Rise in reagent rental agreements
• Implementation of Affordable Care Act( ACA)
• Increasing adoption of automated instruments and automation in laboratories
HISTORICAL DATA OF THE MARKET
IMPACT ANALYSIS OF MARKET TRENDS
MARKET SHARE ANALYSIS COMPETITIVE LANDSCAPE
MARKET OPPORTUNITY:
• Unfavorable reimbursement • New range of condition-specific scenario tests and markers with advances in
• Rising healthcare cost and low genomics and proteomics budget of laboratories limits the adoption of novel disease
MARKET CHALLENGE: diagnostic tests
• Stringent regulatory framework
• NEW PRODUCT LAUNCHES: Accounted for 43 % of the overall developments during
• COLLABORATIONS, PARTNERSHIPS & AGREEMENTS: Accounted for 23 % of the
• APPROVALS: Accounted for 17 % of the overall developments during 2012 to 2016
• MERGERS & ACQUISITIONS: Accounted for 12 % of the overall developments during
GEOGRAPHICAL ANALYSIS: Market dynamics and business environment in the
MARKET RESTRAINTS:
U. S.
U. S. IVD MARKET SIZE & FORECAST:
© MarketsandMarkets
• Market Research and Consulting Firms
• Venture Capitalists and Investors
15
• By Products & Services
2012 to 2016
overall developments during 2012 to 2016
2012 to 2016
DEMAND SIDE
U. S. In Vitro Diagnostics( IVD) Market – Forecast to 2020
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION
After arriving at the market size from the market size estimation process explained above, the U. S. IVD market was divided into several segments and subsegments. In order to complete the overall market engineering process and arrive at the exact statistics for all the segments and subsegments, data triangulation and market breakdown procedures were employed, wherever applicable.
The following figure shows the market validation sources structure and the data triangulation methodology implemented in the market engineering process for making this report.
FIGURE 5 DATA TRIANGULATION METHODOLOGY
PRIMARY SOURCES
INTERVIEWS WITH:
• Hospitals
• Clinics
• Laboratories
• By Application
• By End User
• By Technology
INTERVIEWS WITH:
• Presidents, CEOs, Vice Presidents, Directors, General Managers, Heads of IVD Business Segments, and Senior Managers
ARRIVE AT THE MARKET SIZE, SHARE, AND CAGR FOR THE
U. S. IVD MARKET
• Product / Sales / Marketing / B usiness / Development Client Portfolio Managers or Specialists, Distributors / Suppliers / Channel
Intelligence Consultants
SUPPLY SIDE
Partners, and Business
PRIMARY SOURCE
MnM KNOW *
DATA TRIANGULATION
SECONDARY SOURCES
Annual Reports, Presentations, Websites, and Press Releases of Top Players; News Articles; Journals; and Paid Databases
16
SECONDARY SOURCE
• American Association for Clinical Chemistry( AACC)
• American Diabetes Association( ADA)
• National Accreditation Board for Testing and Calibration
© MarketsandMarkets
© MarketsandMarkets
Key Players Competitive Landscape
Drivers and Restraints
INFORMATION SOURCED
Opportunities and Challenges
• Centers for Disease Control and Prevention( CDC)
• World Health Organization( WHO)
Market Size( 2015) and Market Share( 2014)
MnM KNOW * stands for MarketsandMarkets’ ' Knowledge Asset Management ' framework. In this context, it stands for existing market research knowledge repository of over 5,000 granular markets, our flagship competitive intelligence and market research platform " RT ", subject matter experts, and independent consultants. MnM KNOW acts as an independent source that helps us validate information gathered from primary and secondary sources.
© MarketsandMarkets
17 sales @ marketsandmarkets. com www. marketsandmarkets. com
25